Skip Navigation

European Heart Journal 1997 18(Supplement A):134-138; doi:10.1093/eurheartj/18.suppl_A.134
Copyright © 1997 by the European Society of Cardiology.
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Opie, L. H.
Right arrow Articles by Hansen, J. F.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Opie, L. H.
Right arrow Articles by Hansen, J. F.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1997 The European Society of Cardiology

How European cardiologists perceive the role of calcium antagonists in follow-up after myocardial infarction

L. H. Opie, T. F. Lüscher*, R. Ferrari{dagger}, and J. Fischer Hansen{ddagger}

Heart Research Unit and Hypertension Clinic, Department of Medicine, University of Cape Town Cape Town, South Africa
* University Hospital Zürich, Switzerland
{dagger} Chair of Cardiology, University of Brescia Brescia, IRCCS Salvatore Maugeri Foundation Gussago, Brescia, Italy
{ddagger} Department of Cardiology, Hvidovre Hospital, University of Copenhagen Denmark

Correspondence: Prof. Roberto Ferrari, Chair of Cardiology, University of Brescia, Spedali Civili, P.le Spedali Civili, 1, 25123 Brescia, Italy

About one hundred European cardiologists discussed the role of calcium antagonists in the follow-up management of myocardial infarction, β-blockers are the treatment of choice. Where these are contra-indicated or otherwise unsuitable, many clinicians would use a non-dihydropyridine calcium antagonist alone or in combination with an ACE inhibitor. There is broad agreement that calcium antagonists should not be used in patients with concomitant left ventricular failure. Cholesterol estimation in post-infarction patients is essential.

Key Words: Calcium antagonists • myocardial infarction • beta-blockers • left ventricular failure • ACE inhibitors • cholesterol


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Eur Heart JHome page
A.U Khand, A.C Rankin, G.C Kaye, and J.G.F Cleland
Systematic review of the management of atrial fibrillation in patients with heart failure
Eur. Heart J., April 2, 2000; 21(8): 614 - 632.
[Abstract] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.